Technical Analysis for CALA - Calithera Biosciences, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
4.46 | -2.41% | -0.11 |
CALA closed down 2.41 percent on Friday, January 18, 2019, on 46 percent of normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| See historical CALA trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Jan 18 | 50 DMA Resistance | Bearish | 0.00% |
| Jan 18 | Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% |
| Jan 18 | Stochastic Reached Overbought | Strength | 0.00% |
| Jan 18 | Weak + Overbought | Other | 0.00% |
| Jan 18 | Overbought Stochastic | Strength | 0.00% |
| Jan 17 | 50 DMA Resistance | Bearish | -2.41% |
| Jan 17 | Up 3 Days in a Row | Strength | -2.41% |
| Jan 15 | Narrow Range Bar | Range Contraction | 4.21% |
| Jan 15 | NR7 | Range Contraction | 4.21% |
| Jan 14 | Overbought Stochastic | Strength | 5.44% |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 2018-11-07
- Sector: Healthcare
- Industry: Bio Therapeutic Drugs
Calithera Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer. Its lead product candidate includes CB-839, an inhibitor of glutaminase, which is in three Phase I clinical trials for the treatment of patients with solid tumors, leukemias, lymphomas, and multiple myeloma. The company was founded in 2010 and is headquartered in South San Francisco, California.
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more CALA news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 9.35 |
| 52 Week Low | 3.55 |
| Average Volume | 281,568 |
| 200-Day Moving Average | 5.0582 |
| 50-Day Moving Average | 4.5827 |
| 20-Day Moving Average | 4.1895 |
| 10-Day Moving Average | 4.417 |
| Average True Range | 0.2661 |
| ADX | 17.32 |
| +DI | 22.1402 |
| -DI | 13.6588 |
| Chandelier Exit (Long, 3 ATRs ) | 3.8617 |
| Chandelier Exit (Short, 3 ATRs ) | 4.3483 |
| Upper Bollinger Band | 4.7731 |
| Lower Bollinger Band | 3.6059 |
| Percent B (%b) | 0.73 |
| BandWidth | 27.860127 |
| MACD Line | -0.0205 |
| MACD Signal Line | -0.0768 |
| MACD Histogram | 0.0563 |
| Fundamentals | Value |
|---|---|
| Market Cap | 158.22 Million |
| Num Shares | 35.5 Million |
| EPS | -1.14 |
| Price-to-Earnings (P/E) Ratio | -3.91 |
| Price-to-Sales | 47.73 |
| Price-to-Book | 3.36 |
| PEG Ratio | -0.25 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.78 | ||||
| Resistance 3 (R3) | 4.80 | 4.73 | 4.72 | ||
| Resistance 2 (R2) | 4.73 | 4.65 | 4.71 | 4.70 | |
| Resistance 1 (R1) | 4.59 | 4.60 | 4.56 | 4.57 | 4.69 |
| Pivot Point | 4.52 | 4.52 | 4.50 | 4.50 | 4.52 |
| Support 1 (S1) | 4.38 | 4.44 | 4.35 | 4.36 | 4.23 |
| Support 2 (S2) | 4.31 | 4.39 | 4.29 | 4.22 | |
| Support 3 (S3) | 4.17 | 4.31 | 4.20 | ||
| Support 4 (S4) | 4.15 |
